• Blog
  • Hemoglobin A1c Testing Devices Market Report

    Hemoglobin A1c Testing Devices Market Report

    Hemoglobin A1c Testing Devices Market Report
    Report code - SR1941 Delivery - 2 Weeks
    Hemoglobin A1c Testing Devices Market Size, Share, Trend, Forecast, & Industry Analysi See more...

    Market Insights

    The Hemoglobin A1c Testing Devices Market is estimated to grow from USD 1.2 billion in 2020 to USD 2.1 billion by 2026 at a healthy CAGR of 9.6% during the forecast period.

    Hemoglobin A1c Testing Devices Market- Research Scope

    Base Year of Study

    2020

    Trend Period

    2015-2019

    Forecast Period

    2021-2026

    Market Size in 2020

    US$ 1.2 billion

    Market Size in 2026

    US$ 2.1 billion

    Market Growth

    9.6% CAGR

     

    Figure: Hemoglobin A1c Testing Devices Market Size, 2020-2026 (USD Billion)

    Wish to get a free sample? Register Here

    What is Hemoglobin A1c Testing Devices?

    Hemoglobin A1c, also referred to as glycated hemoglobin is hemoglobin with glucose attached. Hemoglobin A1c testing devices are primarily employed in the blood test which offers information about one’s average levels of blood glucose, also known as blood sugar, over last 3 months. The A1c test can be utilized to detect type1, type 2 diabetes, and prediabetes. Also, it is the primary test method used for diabetes management. For patients who are diabetic, measuring HbA1c concentration in the blood facilitates the long-term monitoring of blood glucose levels.

    Covid-19 Impact Analysis

    The COVID-19 pandemic has positively influenced the Hemoglobin A1c Testing Devices industry. The rapid spread of COVID-19 has resulted in several thousands of hospital admissions. This resulted in increasing testing and sample collection of COVID-19 suspected cases as well as blood tests to check the blood profile in diabetic patients.

    Key Players

    Key players operating in the Hemoglobin A1c Testing Devices Market are-

    • Abbott Laboratories (US)
    • Tosoh Corporation (Japan)
    • Transasia Biomedicals limited (India)
    • Alere Incorporated (US)
    • Arkray Incorporated (Japan)
    • Danaher Co (US)
    • Bio-Rad Laboratories (US)
    • Siemens Healthcare (Germany)
    • F.Hoffmann-La Roche Limited (Switzerland)
    • Trinity Biotech Plc (Ireland)

    Market Dynamics

    The Hemoglobin A1c Testing Devices market is majorly propelled by growing incidences of diabetes and related lifestyle diseases. Diabetes is one of the common health condition of current times, the prevalence of which is likely to increase in the near future. Moreover, increasing geriatric population worldwide with type 1 and 2 diabetes is another key factor boosting the market growth. In addition, surging healthcare concern coupled with public awareness regarding preventive care & rising support by the government in the emerging countries further augments the industry growth.

    Segments Analysis

    Technology Trends

    Based on technology, the hemoglobin A1c testing devices market has been classified into Ion-Exchange High-Performance Liquid Chromatography (HPLC), immunoassay, boronate affinity chromatography, direct enzymatic assay, and others. The Ion-Exchange High-Performance Liquid Chromatography (HPLC) segment accounted for the largest market in 2020. It is a gold standard technique of determination of HbA1c owing to its superior specificity and reproducibility, thus bolsters the segment growth.

    Regional Trends

    By region, the North America Hemoglobin A1c Testing Devices market accounted the highest share in 2020 and is expected to grow at a robust CAGR during the review period. The Hemoglobin A1c Testing Devices market growth is mainly attributed to strong presence a properly structured health care sector, well-established healthcare system, rising prevalence of diabetes, growing geriatric population in the region, and high healthcare expenditure.

    The Asia Pacific Hemoglobin A1c Testing Devices market is expected to grow at the healthy CAGR during the review period due to surge in the healthcare expenditure by the government, surging incidences of diabetes, and developing healthcare infrastructure in emerging countries of India and China, further bolsters the regional market growth.

    Critical Questions Answered in the Report

    This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the hemoglobin A1c testing devices market. The historic years considered for the study are 2016-2019, base year is 2020, estimated year is 2021, and forecast period is 2022-2026. Following are the critical questions answered in the report.

    • What are the key trends in the hemoglobin A1c testing devices market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in next five years?
    • What is the impact of COVID-19 on hemoglobin A1c testing devices market?
    • What are the key strategies adopted by the major vendors to lead in the hemoglobin A1c testing devices market?
    • What is the market share of the top vendors?

    Target Audience

    The target audience of Hemoglobin A1c Testing Devices Market includes-

    • Hemoglobin A1c Testing Devices Vendors
    • Hemoglobin A1c Testing Devices Manufacturers
    • Hemoglobin A1c Testing Devices Distributors
    • Organizations
    • Government Bodies.

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The Hemoglobin A1c Testing Devices Market is estimated to grow from USD 1.2 billion in 2020 to USD 2.1 billion by 2026 at a healthy CAGR of 9.6% during the forecast period.

    Key players operating in the Hemoglobin A1c Testing Devices Market are Abbott Laboratories (US), Tosoh Corporation (Japan), Transasia Biomedicals limited (India), Alere Incorporated (US), Arkray Incorporated (Japan), Danaher Co (US), Bio-Rad Laboratories (US), Siemens Healthcare (Germany), F.Hoffmann-La Roche Limited (Switzerland), Trinity Biotech Plc (Ireland).

    The target audience of Hemoglobin A1c Testing Devices Market includes Hemoglobin A1c Testing Devices Vendors, Hemoglobin A1c Testing Devices Manufacturers, Hemoglobin A1c Testing Devices Distributors, Organizations, Government Bodies.

    North America Hemoglobin A1c Testing Devices market accounted the highest share in 2020 and is expected to grow at a robust CAGR during the review period.

    The Hemoglobin A1c Testing Devices market is majorly propelled by growing incidences of diabetes and related lifestyle diseases. Diabetes is one of the common health condition of current times, the prevalence of which is likely to increase in the near future.